BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28905133)

  • 1. RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.
    Pieringer H; Hintenberger R; Pohanka E; Steinwender C; Meier J; Gruber F; Auer-Hackenberg L
    Clin Rheumatol; 2017 Nov; 36(11):2439-2445. PubMed ID: 28905133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.
    Marrie RA; Hitchon CA; Peschken CA; Chen H; Bernstein CN; Garland A
    Clin Exp Rheumatol; 2017; 35(6):975-982. PubMed ID: 28598781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
    Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of Sepsis in Patients With Rheumatoid Arthritis: A Single-Center Retrospective Analysis and Comparison With a Control Group.
    Krasselt M; Baerwald C; Petros S; Seifert O
    J Intensive Care Med; 2021 Jul; 36(7):766-774. PubMed ID: 32249644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.
    Chiu YM; Lang HC; Lin HY; Yang MT; Fang CH; Yang YW; Schabert VF; Tang B
    Int J Rheum Dis; 2014 Dec; 17 Suppl 3():9-19. PubMed ID: 25496045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Mena-Vazquez N; Manrique-Arija S; Yunquera-Romero L; Ureña-Garnica I; Rojas-Gimenez M; Domic C; Jimenez-Nuñez FG; Fernandez-Nebro A
    Rheumatol Int; 2017 Oct; 37(10):1709-1718. PubMed ID: 28631046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Population-based Study of Intensive Care Unit Admissions in Rheumatoid Arthritis.
    Peschken CA; Hitchon CA; Garland A; Bernstein CN; Chen H; Fransoo R; Marrie RA
    J Rheumatol; 2016 Jan; 43(1):26-33. PubMed ID: 26628597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study.
    Hudson M; Dell'Aniello S; Shen S; Simon TA; Ernst P; Suissa S
    Rheumatology (Oxford); 2020 Apr; 59(4):820-827. PubMed ID: 31504972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
    Meissner Y; Zink A; Kekow J; Rockwitz K; Liebhaber A; Zinke S; Gerhold K; Richter A; Listing J; Strangfeld A
    Arthritis Res Ther; 2016 Aug; 18(1):183. PubMed ID: 27495156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
    Cho SK; Lee J; Han M; Bae SC; Sung YK
    Arthritis Res Ther; 2017 Dec; 19(1):277. PubMed ID: 29246243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Luque Ramos A; Albrecht K; Zink A; Hoffmann F
    Rheumatol Int; 2017 Dec; 37(12):2059-2064. PubMed ID: 28821941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis.
    Sung YK; Cho SK; Kim D; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim HA; Kim J; Kim SK; Kim TH; Lee HS; Lee J; Lee J; Lee SS; Lee SW; Lee YA; Nah SS; Suh CH; Yoo DH; Yoon BY; Bae SC;
    Rheumatol Int; 2017 Jun; 37(6):975-982. PubMed ID: 28132102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus sepsis in rheumatoid arthritis.
    Sams M; Olsen MA; Joshi R; Ranganathan P
    Rheumatol Int; 2015 Sep; 35(9):1503-10. PubMed ID: 25758228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
    Bernatsky S; Hudson M; Suissa S
    Rheumatology (Oxford); 2007 Jul; 46(7):1157-60. PubMed ID: 17478469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
    Kawashima H; Kagami SI; Kashiwakuma D; Takahashi K; Yokota M; Furuta S; Iwamoto I
    Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.
    Black RJ; Lester S; Buchbinder R; Barrett C; Lassere M; March L; Whittle S; Hill CL
    Arthritis Res Ther; 2017 Nov; 19(1):253. PubMed ID: 29141677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.
    Hashimoto T; Yoshida K; Hashimoto N; Nakai A; Kaneshiro K; Suzuki K; Kawasaki Y; Shibanuma N; Hashiramoto A
    Int J Rheum Dis; 2017 Jun; 20(6):722-730. PubMed ID: 27943573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia.
    Machado-Alba JE; Ruiz AF; Machado-Duque ME
    Int J Clin Pract; 2016 Jun; 70(6):506-11. PubMed ID: 27238964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of pneumonia in patients with rheumatoid arthritis: the role of medication and disease activity prior to admission a population-based cohort study.
    Holland-Fischer M; Thomsen RW; Tarp U; Nørgaard M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.